Literature DB >> 9037515

The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair.

M Walton1, E Sirimanne, C Williams, P Gluckman, M Dragunow.   

Abstract

The cyclic AMP-responsive element binding protein (CREB) is a basally expressed, post-translationally activated transcription factor that has been implicated in the trans-activation of a number of genes in response to cAMP and calcium signals. A unilateral hypoxic-ischemic (HI) injury in the 21 day old rat was used to examine a potential role for CREB (phosphorylated and unphosphorylated) in neuronal programmed cell death or cell survival. The selectively vulnerable CAI pyramidal cells, which undergo delayed neuronal death following mild HI, show a loss of CREB and phosphorylated CREB (pCREB) immunoreactivity on the injured side 48 and 72 h following HI. In contrast the resistant dentate granule cells and cortical cells produce a bimodal increase in pCREB immunoreactivity, peaking 6 and 48 h following HI. The fact that cells surviving the HI insult are showing increased activation of CREB suggests that this protein might be involved in the process of neuroprotection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9037515     DOI: 10.1016/s0169-328x(96)00144-1

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  24 in total

1.  Aberrant expression of cAMP-response-element-binding protein ('CREB') induces apoptosis.

Authors:  K Saeki; A Yuo; E Suzuki; Y Yazaki; F Takaku
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats.

Authors:  M De Butte-Smith; R S Zukin; A M Etgen
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

3.  Early regional response of apoptotic activity in newborn piglet brain following hypoxia and ischemia.

Authors:  A Pirzadeh; A Mammen; J Kubin; E Reade; H Liu; A Mendoza; W J Greeley; D F Wilson; A Pastuszko
Journal:  Neurochem Res       Date:  2010-09-26       Impact factor: 3.996

4.  Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo.

Authors:  T Mabuchi; K Kitagawa; K Kuwabara; K Takasawa; T Ohtsuki; Z Xia; D Storm; T Yanagihara; M Hori; M Matsumoto
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability.

Authors:  Francesc X Soriano; Sofia Papadia; Frank Hofmann; Neil R Hardingham; Hilmar Bading; Giles E Hardingham
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

6.  Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.

Authors:  Wanlu Du; Junbo Huang; Hailan Yao; Kechun Zhou; Bo Duan; Yizheng Wang
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

7.  Inhibition of phosphorylation of JNK suppresses Aβ-induced ER stress and upregulates prosurvival mitochondrial proteins in rat hippocampus.

Authors:  Parvin Yenki; Fariba Khodagholi; Fatemeh Shaerzadeh
Journal:  J Mol Neurosci       Date:  2012-06-17       Impact factor: 3.444

8.  NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection.

Authors:  Nikolaos Volakakis; Banafsheh Kadkhodaei; Eliza Joodmardi; Karin Wallis; Lia Panman; Jessica Silvaggi; Bruce M Spiegelman; Thomas Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

9.  Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice.

Authors:  Nobukazu Miyamoto; Takakuni Maki; Loc-Duyen D Pham; Kazuhide Hayakawa; Ji Hae Seo; Emiri T Mandeville; Joseph B Mandeville; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  Stroke       Date:  2013-09-26       Impact factor: 7.914

10.  Cyclic adenosine monophosphate response element-binding protein phosphorylation and neuroprotection by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP).

Authors:  Sufang Yang; Nabil J Alkayed; Patricia D Hurn; Jeffrey R Kirsch
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.